Skip to main content
Erschienen in: Head and Neck Pathology 4/2022

26.07.2022 | Original Paper

Endotype of Chronic Rhinosinusitis with Nasal Polyps in Morocco

verfasst von: Youssef Darouassi, Mohamed Amine Azami, Mohamed El-Akhiri, Iliass Benchafai, Mohamed Amine Hanine, Mohamed Amine Haouane, Youness Chebraoui, Mossab Tayane, Issam Rharrassi, Mohamed Mliha Touati, Abdelfettah Aljalil, Haddou Ammar

Erschienen in: Head and Neck Pathology | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

With the advent of biotherapies, endotyping of chronic rhinosinusitis with nasal polyps (CRSwNP) is becoming more and more important to optimize therapeutic management. While the majority of CRSwNPs in the United States, Europe, and Japan exhibit type 2 eosinophil-dominant inflammation response, other parts of Asia display mixed patterns including neutrophil-dominant inflammation. Until now, no study has focused on the proportion of inflammation patterns in Morocco or anywhere on the African continent. We aim to fill this gap by studying tissue inflammatory response in our operated patients.

Material and methods

After searching the database of the pathology department, we retrieved from the archives the stained pathology slides of all our patients who underwent surgery for CRSwNP over 5 years from 2017 to 2021. We counted then the number of eosinophils in the lamina propria at high-power magnification to determine the predominant inflammatory pattern.

Results

A total of 35 reports were collected. We found that eosinophilic inflammation was predominant, accounting for 97% of the cases.

Conclusions

The CRSwNP endotype in our region would mainly be type 2. However, our results must be confirmed by multicenter studies involving a large number of patients.
Literatur
1.
Zurück zum Zitat Bartier S, Coste A, Bequignon E. Management strategies for chronic rhinosinusitis with nasal polyps in adults. Rev Mal Respir. 2021;38:183–98.CrossRef Bartier S, Coste A, Bequignon E. Management strategies for chronic rhinosinusitis with nasal polyps in adults. Rev Mal Respir. 2021;38:183–98.CrossRef
2.
Zurück zum Zitat Cho SH, Hamilos DL, Han DH, Laidlaw TM. Phenotypes of chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2020;8:1505–11.CrossRef Cho SH, Hamilos DL, Han DH, Laidlaw TM. Phenotypes of chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2020;8:1505–11.CrossRef
3.
Zurück zum Zitat Workman AD, Kohanski MA, Cohen NA. Biomarkers in chronic rhinosinusitis with nasal polyps. Immunol Allergy Clin North Am. 2018;38:679–92.CrossRef Workman AD, Kohanski MA, Cohen NA. Biomarkers in chronic rhinosinusitis with nasal polyps. Immunol Allergy Clin North Am. 2018;38:679–92.CrossRef
4.
Zurück zum Zitat Adnane C, Adouly T, Khallouk A, Rouadi S, Abada R, Roubal M, et al. Using preoperative unsupervised cluster analysis of chronic rhinosinusitis to inform patient decision and endoscopic sinus surgery outcome. Eur Arch Oto-Rhino-Laryngol. 2017;274:879–85.CrossRef Adnane C, Adouly T, Khallouk A, Rouadi S, Abada R, Roubal M, et al. Using preoperative unsupervised cluster analysis of chronic rhinosinusitis to inform patient decision and endoscopic sinus surgery outcome. Eur Arch Oto-Rhino-Laryngol. 2017;274:879–85.CrossRef
5.
Zurück zum Zitat Adnane C, Adouly T, Zouak A, Mahtar M. Quality of life outcomes after functional endoscopic sinus surgery for nasal polyposis. Am J Otolaryngol. 2015;36:47–51.CrossRef Adnane C, Adouly T, Zouak A, Mahtar M. Quality of life outcomes after functional endoscopic sinus surgery for nasal polyposis. Am J Otolaryngol. 2015;36:47–51.CrossRef
6.
Zurück zum Zitat Lahjaouj M, Laachoubi M, Bouhmadi KE, Oukessou Y, Rouadi S, Abada R, et al. Impact of asthma on endoscopic sinus surgery outcomes for chronic rhinosinusitis with polyposis—a cohort study. Ann Med Surg. 2012;2021(66):102386. Lahjaouj M, Laachoubi M, Bouhmadi KE, Oukessou Y, Rouadi S, Abada R, et al. Impact of asthma on endoscopic sinus surgery outcomes for chronic rhinosinusitis with polyposis—a cohort study. Ann Med Surg. 2012;2021(66):102386.
7.
Zurück zum Zitat Laidlaw TM, Buchheit KM. Biologics in chronic rhinosinusitis with nasal polyposis. Ann Allergy Asthma Immunol. 2020;124:326–32.CrossRef Laidlaw TM, Buchheit KM. Biologics in chronic rhinosinusitis with nasal polyposis. Ann Allergy Asthma Immunol. 2020;124:326–32.CrossRef
8.
Zurück zum Zitat Bachert C, Marple B, Hosemann W, Cavaliere C, Wen W, Zhang N. Endotypes of chronic rhinosinusitis with nasal polyps: pathology and possible therapeutic implications. J Allergy Clin Immunol Pract. 2020;8:1514–9.CrossRef Bachert C, Marple B, Hosemann W, Cavaliere C, Wen W, Zhang N. Endotypes of chronic rhinosinusitis with nasal polyps: pathology and possible therapeutic implications. J Allergy Clin Immunol Pract. 2020;8:1514–9.CrossRef
9.
Zurück zum Zitat Bachert C, Zhang N. Chronic rhinosinusitis and asthma: novel understanding of the role of IgE ‘above atopy.’ J Intern Med. 2012;272:133–43.CrossRef Bachert C, Zhang N. Chronic rhinosinusitis and asthma: novel understanding of the role of IgE ‘above atopy.’ J Intern Med. 2012;272:133–43.CrossRef
10.
Zurück zum Zitat Tomassen P, Vandeplas G, Van Zele T, Cardell L-O, Arebro J, Olze H, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137:1449-56.e4.CrossRef Tomassen P, Vandeplas G, Van Zele T, Cardell L-O, Arebro J, Olze H, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137:1449-56.e4.CrossRef
11.
Zurück zum Zitat Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58:1–464.CrossRef Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58:1–464.CrossRef
12.
Zurück zum Zitat Pan L, Liao B, Guo C-L, Liu J-X, Wang H, Long X-B, et al. Inflammatory features and predictors for postsurgical outcomes in patients with nasal polyps stratified by local and systemic eosinophilia. Int Forum Allergy Rhinol. 2021;11:846–56.CrossRef Pan L, Liao B, Guo C-L, Liu J-X, Wang H, Long X-B, et al. Inflammatory features and predictors for postsurgical outcomes in patients with nasal polyps stratified by local and systemic eosinophilia. Int Forum Allergy Rhinol. 2021;11:846–56.CrossRef
13.
Zurück zum Zitat Ruan J-W, Zhao J-F, Li X-L, Liao B, Pan L, Zhu K-Z, et al. Characterizing the neutrophilic inflammation in chronic rhinosinusitis with nasal polyps. Front Cell Dev Biol. 2021;9:793073.CrossRef Ruan J-W, Zhao J-F, Li X-L, Liao B, Pan L, Zhu K-Z, et al. Characterizing the neutrophilic inflammation in chronic rhinosinusitis with nasal polyps. Front Cell Dev Biol. 2021;9:793073.CrossRef
14.
Zurück zum Zitat Scalzo-Inguanti K, Monaghan K, Edwards K, Herzog E, Mirosa D, Hardy M, et al. A neutralizing anti-G-CSFR antibody blocks G-CSF-induced neutrophilia without inducing neutropenia in nonhuman primates. J Leukoc Biol. 2017;102:537–49.CrossRef Scalzo-Inguanti K, Monaghan K, Edwards K, Herzog E, Mirosa D, Hardy M, et al. A neutralizing anti-G-CSFR antibody blocks G-CSF-induced neutrophilia without inducing neutropenia in nonhuman primates. J Leukoc Biol. 2017;102:537–49.CrossRef
15.
Zurück zum Zitat Bachert C, Han JK, Desrosiers MY, Gevaert P, Heffler E, Hopkins C, et al. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2022;149:1309-17.e12.CrossRef Bachert C, Han JK, Desrosiers MY, Gevaert P, Heffler E, Hopkins C, et al. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2022;149:1309-17.e12.CrossRef
16.
Zurück zum Zitat Gevaert P, Omachi TA, Corren J, Mullol J, Han J, Lee SE, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146:595–605.CrossRef Gevaert P, Omachi TA, Corren J, Mullol J, Han J, Lee SE, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146:595–605.CrossRef
17.
Zurück zum Zitat Hellings PW, Verhoeven E, Fokkens WJ. State-of-the-art overview on biological treatment for CRSwNP. Rhinology. 2021;59:151–63. Hellings PW, Verhoeven E, Fokkens WJ. State-of-the-art overview on biological treatment for CRSwNP. Rhinology. 2021;59:151–63.
18.
Zurück zum Zitat Patel GB, Peters AT. The role of biologics in chronic rhinosinusitis with nasal polyps. Ear Nose Throat J. 2021;100:44–7.CrossRef Patel GB, Peters AT. The role of biologics in chronic rhinosinusitis with nasal polyps. Ear Nose Throat J. 2021;100:44–7.CrossRef
19.
Zurück zum Zitat Wu Q, Zhang Y, Kong W, Wang X, Yuan L, Zheng R, et al. Which is the best biologic for nasal polyps: dupilumab, omalizumab, or mepolizumab? A network meta-analysis. Int Arch Allergy Immunol. 2022;183:279–88.CrossRef Wu Q, Zhang Y, Kong W, Wang X, Yuan L, Zheng R, et al. Which is the best biologic for nasal polyps: dupilumab, omalizumab, or mepolizumab? A network meta-analysis. Int Arch Allergy Immunol. 2022;183:279–88.CrossRef
20.
Zurück zum Zitat Wang X, Zhang N, Bo M, Holtappels G, Zheng M, Lou H, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016;138:1344–53.CrossRef Wang X, Zhang N, Bo M, Holtappels G, Zheng M, Lou H, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016;138:1344–53.CrossRef
21.
Zurück zum Zitat Bachert C, Zhang N, Hellings PW, Bousquet J. Endotype-driven care pathways in patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2018;141:1543–51.CrossRef Bachert C, Zhang N, Hellings PW, Bousquet J. Endotype-driven care pathways in patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2018;141:1543–51.CrossRef
Metadaten
Titel
Endotype of Chronic Rhinosinusitis with Nasal Polyps in Morocco
verfasst von
Youssef Darouassi
Mohamed Amine Azami
Mohamed El-Akhiri
Iliass Benchafai
Mohamed Amine Hanine
Mohamed Amine Haouane
Youness Chebraoui
Mossab Tayane
Issam Rharrassi
Mohamed Mliha Touati
Abdelfettah Aljalil
Haddou Ammar
Publikationsdatum
26.07.2022
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 4/2022
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-022-01477-y

Weitere Artikel der Ausgabe 4/2022

Head and Neck Pathology 4/2022 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …